{"ticker": "PVCT", "overview": {"cik": "315545", "ticker": "PVCT", "name": "PROVECTUS BIOPHARMACEUTICALS, INC.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "4", "date": "2026-10-30", "title": "Insider transaction", "accession": "0001493152-26-049383", "price_sensitive": false}, {"form": "4", "date": "2026-10-23", "title": "Insider transaction", "accession": "0001493152-26-048321", "price_sensitive": false}, {"form": "4", "date": "2026-10-13", "title": "Insider transaction", "accession": "0001493152-26-046701", "price_sensitive": false}, {"form": "4", "date": "2026-10-05", "title": "Insider transaction", "accession": "0001493152-26-045713", "price_sensitive": false}, {"form": "4", "date": "2026-09-18", "title": "Insider transaction", "accession": "0001493152-26-043276", "price_sensitive": false}, {"form": "4", "date": "2026-09-11", "title": "Insider transaction", "accession": "0001493152-26-042331", "price_sensitive": false}, {"form": "4", "date": "2026-09-08", "title": "Insider transaction", "accession": "0001493152-26-041727", "price_sensitive": false}, {"form": "4", "date": "2026-08-26", "title": "Insider transaction", "accession": "0001493152-26-040207", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-13", "title": "Quarterly report", "accession": "0001493152-26-037671", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-07-22", "title": "Form SCHEDULE 13D/A", "accession": "0001493152-26-034217", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001493152-26-031718", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-01", "title": "Material event", "accession": "0001493152-26-031379", "price_sensitive": true}, {"form": "4", "date": "2026-06-30", "title": "Insider transaction", "accession": "0001493152-26-031404", "price_sensitive": false}, {"form": "4", "date": "2026-06-30", "title": "Insider transaction", "accession": "0001493152-26-031403", "price_sensitive": false}, {"form": "4", "date": "2026-06-30", "title": "Insider transaction", "accession": "0001493152-26-031402", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-22", "title": "Material event", "accession": "0001493152-26-029512", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-18", "title": "Material event", "accession": "0001493152-26-029280", "price_sensitive": true}, {"form": "4", "date": "2026-06-05", "title": "Insider transaction", "accession": "0001493152-26-027467", "price_sensitive": false}, {"form": "4", "date": "2026-05-29", "title": "Insider transaction", "accession": "0001493152-26-026269", "price_sensitive": false}, {"form": "4", "date": "2026-05-26", "title": "Insider transaction", "accession": "0001493152-26-025188", "price_sensitive": false}, {"form": "4", "date": "2026-05-15", "title": "Insider transaction", "accession": "0001493152-26-023486", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-14", "title": "Quarterly report", "accession": "0001493152-26-022950", "price_sensitive": true}, {"form": "4", "date": "2026-05-07", "title": "Insider transaction", "accession": "0001493152-26-021663", "price_sensitive": false}, {"form": "ARS", "date": "2026-04-30", "title": "Form ARS", "accession": "0001493152-26-019810", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-30", "title": "Form DEFA14A", "accession": "0001493152-26-019807", "price_sensitive": false}]}, "description": "PROVECTUS BIOPHARMACEUTICALS, INC. trades as PVCT and is registered in the United States, classified under Pharmaceutical Preparations (SIC 2834). Privy Trades holds 346 insider filings for the company, from December 2003 to December 2017. Across those, 6 insiders disclosed 8 open-market purchases totalling $1.70M against 1 sale totalling $13.59K. The most recent filing on record is dated 30 October 2026.", "exchange": null, "stats": {"buy_n": 8, "buy_sum": 1698121.1400000001, "sell_n": 1, "sell_sum": 13592.0, "net": 1684529.1400000001, "insiders": 6, "first_date": "2003-12-09", "last_date": "2017-12-14"}, "metrics": {"ticker": "PVCT", "has_prices": false}, "trades": [{"id": "0001493152-26-049383", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1689739/000149315226049383/0001493152-26-049383-index.htm", "trade_date": "2026-10-30", "timestamp": "2026-10-30", "mins": 5205}, {"id": "0001493152-26-048321", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1689739/000149315226048321/0001493152-26-048321-index.htm", "trade_date": "2026-10-23", "timestamp": "2026-10-23", "mins": 15285}, {"id": "0001493152-26-046701", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1689739/000149315226046701/0001493152-26-046701-index.htm", "trade_date": "2026-10-10", "timestamp": "2026-10-10", "mins": 34005}, {"id": "0001493152-26-041727", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1689739/000149315226041727/0001493152-26-041727-index.htm", "trade_date": "2026-09-04", "timestamp": "2026-09-04", "mins": 85845}, {"id": "0001493152-26-040207", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1689739/000149315226040207/0001493152-26-040207-index.htm", "trade_date": "2026-08-26", "timestamp": "2026-08-26", "mins": 98805}, {"id": "13DG-0001493152-26-034217", "src": "13DG", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Provectus Biopharmaceuticals, Inc.", "who_key": "PROVECTUS BIOPHARMACEUTICALS, INC.", "role": "Substantial holder \u00b7 13D/A", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "PROVECTUS BIOPHARMACEUTICALS, INC. moves to a 11.61% activist stake in PVCT", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-034217-index.htm", "trade_date": "2026-07-22", "timestamp": "2026-07-22", "mins": 149205}, {"id": "0001493152-26-031402", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Webster Bailey", "who_key": "Bailey Webster", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226031402/0001493152-26-031402-index.htm", "trade_date": "2026-06-30", "timestamp": "2026-06-30", "mins": 180885}, {"id": "0001493152-26-031403", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "John Lacey III", "who_key": "Lacey John III", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226031403/0001493152-26-031403-index.htm", "trade_date": "2026-06-30", "timestamp": "2026-06-30", "mins": 180885}, {"id": "0001493152-26-031404", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Dominic Rodrigues", "who_key": "Rodrigues Dominic", "role": "PRESIDENT, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "President files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226031404/0001493152-26-031404-index.htm", "trade_date": "2026-06-30", "timestamp": "2026-06-30", "mins": 180885}, {"id": "0001493152-26-031718", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226031718/0001493152-26-031718-index.htm", "trade_date": "2026-06-30", "timestamp": "2026-06-30", "mins": 180885}, {"id": "0001493152-26-027467", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226027467/0001493152-26-027467-index.htm", "trade_date": "2026-06-05", "timestamp": "2026-06-05", "mins": 216885}, {"id": "0001493152-26-026269", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226026269/0001493152-26-026269-index.htm", "trade_date": "2026-05-28", "timestamp": "2026-05-28", "mins": 228405}, {"id": "0001493152-26-025188", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226025188/0001493152-26-025188-index.htm", "trade_date": "2026-05-23", "timestamp": "2026-05-23", "mins": 235605}, {"id": "0001493152-26-023486", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226023486/0001493152-26-023486-index.htm", "trade_date": "2026-05-15", "timestamp": "2026-05-15", "mins": 247125}, {"id": "0001493152-26-021663", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226021663/0001493152-26-021663-index.htm", "trade_date": "2026-05-07", "timestamp": "2026-05-07", "mins": 258645}, {"id": "0001493152-26-019644", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226019644/0001493152-26-019644-index.htm", "trade_date": "2026-04-29", "timestamp": "2026-04-29", "mins": 270165}, {"id": "0001493152-26-015333", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226015333/0001493152-26-015333-index.htm", "trade_date": "2026-04-04", "timestamp": "2026-04-04", "mins": 306165}, {"id": "0001493152-26-012837", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226012837/0001493152-26-012837-index.htm", "trade_date": "2026-03-25", "timestamp": "2026-03-25", "mins": 320565}, {"id": "0001493152-26-011771", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226011771/0001493152-26-011771-index.htm", "trade_date": "2026-03-20", "timestamp": "2026-03-20", "mins": 327765}, {"id": "0001493152-26-010381", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226010381/0001493152-26-010381-index.htm", "trade_date": "2026-03-12", "timestamp": "2026-03-12", "mins": 339285}, {"id": "0001493152-26-009081", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226009081/0001493152-26-009081-index.htm", "trade_date": "2026-03-05", "timestamp": "2026-03-05", "mins": 349365}, {"id": "0001493152-26-008290", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226008290/0001493152-26-008290-index.htm", "trade_date": "2026-02-26", "timestamp": "2026-02-26", "mins": 359445}, {"id": "0001493152-26-007732", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226007732/0001493152-26-007732-index.htm", "trade_date": "2026-02-20", "timestamp": "2026-02-20", "mins": 368085}, {"id": "0001493152-26-007729", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226007729/0001493152-26-007729-index.htm", "trade_date": "2026-02-19", "timestamp": "2026-02-19", "mins": 369525}, {"id": "0001493152-26-006978", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226006978/0001493152-26-006978-index.htm", "trade_date": "2026-02-12", "timestamp": "2026-02-12", "mins": 379605}, {"id": "0001493152-26-006263", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226006263/0001493152-26-006263-index.htm", "trade_date": "2026-02-09", "timestamp": "2026-02-09", "mins": 383925}, {"id": "0001493152-26-005744", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226005744/0001493152-26-005744-index.htm", "trade_date": "2026-02-05", "timestamp": "2026-02-05", "mins": 389685}, {"id": "0001493152-26-004708", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226004708/0001493152-26-004708-index.htm", "trade_date": "2026-01-30", "timestamp": "2026-01-30", "mins": 398325}, {"id": "0001493152-26-004236", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226004236/0001493152-26-004236-index.htm", "trade_date": "2026-01-28", "timestamp": "2026-01-28", "mins": 401205}, {"id": "0001493152-26-002508", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Edward Pershing", "who_key": "Pershing Edward", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PVCT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000149315226002508/0001493152-26-002508-index.htm", "trade_date": "2026-01-16", "timestamp": "2026-01-16", "mins": 418485}], "recent_buys": [{"id": "0000899243-17-028955", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "John R. Glass", "who_key": "Glass John R", "role": "See Remarks", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 10791.59, "score": 37.9, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider puts $11K into PVCT", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000089924317028955/0000899243-17-028955-index.htm", "trade_date": "2017-12-14", "timestamp": "2017-12-14", "mins": 4673685}, {"id": "0001140361-13-036922", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS PHARMACEUTICALS INC", "who": "Jan Koe", "who_key": "Koe Jan", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 0.0, "score": 18.1, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "A director backs PVCT with $0", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036113036922/0001140361-13-036922-index.htm", "trade_date": "2013-09-20", "timestamp": "2013-09-20", "mins": 6899925}, {"id": "0001140361-12-049419", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS PHARMACEUTICALS INC", "who": "Peter R. Culpepper", "who_key": "CULPEPPER PETER R", "role": "CFO, COO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 0.0, "score": 25.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying PVCT \u2014 3 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036112049419/0001140361-12-049419-index.htm", "trade_date": "2012-12-03", "timestamp": "2012-12-03", "mins": 7318965}, {"id": "0001140361-12-048272", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS PHARMACEUTICALS INC", "who": "Peter R. Culpepper", "who_key": "CULPEPPER PETER R", "role": "CFO, COO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 0.0, "score": 25.5, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying PVCT \u2014 4 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036112048272/0001140361-12-048272-index.htm", "trade_date": "2012-11-16", "timestamp": "2012-11-16", "mins": 7343445}, {"id": "0001144204-07-050790", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS PHARMACEUTICALS INC", "who": "Donald E. Adams", "who_key": "ADAMS DONALD E", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 713000.4, "score": 48.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying PVCT \u2014 4 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114420407050790/0001144204-07-050790-index.htm", "trade_date": "2007-01-27", "timestamp": "2007-01-27", "mins": 10396245}, {"id": "0001144204-07-050780", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS PHARMACEUTICALS INC", "who": "Donald E. Adams", "who_key": "ADAMS DONALD E", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 713000.4, "score": 48.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying PVCT \u2014 5 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114420407050780/0001144204-07-050780-index.htm", "trade_date": "2007-01-27", "timestamp": "2007-01-27", "mins": 10396245}, {"id": "0001355641-06-000002", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS PHARMACEUTICALS INC", "who": "Donald E. Adams", "who_key": "ADAMS DONALD E", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 62800.0, "score": 34.2, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying PVCT \u2014 5 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000135564106000002/0001355641-06-000002-index.htm", "trade_date": "2006-05-24", "timestamp": "2006-05-24", "mins": 10753365}, {"id": "0001005794-05-000970", "src": "INSIDERS", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS PHARMACEUTICALS INC", "who": "Eric Wachter PhD", "who_key": "WACHTER ERIC PHD", "role": "Vice President Pharmaceuticals, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 198528.75, "score": 50.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 5 insiders into PVCT", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000100579405000970/0001005794-05-000970-index.htm", "trade_date": "2005-12-09", "timestamp": "2005-12-09", "mins": 10992405}], "institutional": [{"id": "13DG-0001493152-26-034217", "src": "13DG", "ticker": "PVCT", "cik": "315545", "company": "PROVECTUS BIOPHARMACEUTICALS, INC.", "company_raw": "PROVECTUS BIOPHARMACEUTICALS, INC.", "who": "Provectus Biopharmaceuticals, Inc.", "who_key": "PROVECTUS BIOPHARMACEUTICALS, INC.", "role": "Substantial holder \u00b7 13D/A", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "PROVECTUS BIOPHARMACEUTICALS, INC. moves to a 11.61% activist stake in PVCT", "source_url": "https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-034217-index.htm", "trade_date": "2026-07-22", "timestamp": "2026-07-22", "mins": 149205}], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "Merged (2017)", "items": [{"action": "DELISTED", "reason": "MERGED", "counterparty": null, "old_value": "PVCT", "new_value": "Merged", "effective": "2017-04-21", "evidence": "Form 25-NSE filed 2017-04-21, following a merger filing on 2016-05-13", "source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000315545", "applied": 1, "detected_at": "2026-08-03T11:19:53.210264"}, {"action": "DELISTED", "reason": "UNKNOWN", "counterparty": null, "old_value": "PVCT", "new_value": "No longer listed", "effective": "", "evidence": "No longer in the listed universe; we have no source stating why.", "source_url": "", "applied": 1, "detected_at": "2026-08-03T11:13:39.874792"}]}, "key_people": [{"who": "Donald E. Adams", "who_key": "ADAMS DONALD E", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 1488800.8, "sold": 0, "net": 1488800.8, "trades": 3, "top_score": 48.8, "lean": "buying", "history": [{"action": "BUY", "amount": 713000.4, "date": "2007-01-27", "score": 48.8, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114420407050780/0001144204-07-050780-index.htm"}, {"action": "BUY", "amount": 713000.4, "date": "2007-01-27", "score": 48.8, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114420407050790/0001144204-07-050790-index.htm"}, {"action": "BUY", "amount": 62800.0, "date": "2006-05-24", "score": 34.2, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000135564106000002/0001355641-06-000002-index.htm"}], "latest": {"action": "BUY", "amount": 713000.4, "date": "2007-01-27", "score": 48.8, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114420407050780/0001144204-07-050780-index.htm"}}, {"who": "Eric Wachter PhD", "who_key": "WACHTER ERIC PHD", "role": "Vice President Pharmaceuticals, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 198528.75, "sold": 0, "net": 198528.75, "trades": 1, "top_score": 50.4, "lean": "buying", "history": [{"action": "BUY", "amount": 198528.75, "date": "2005-12-09", "score": 50.4, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000100579405000970/0001005794-05-000970-index.htm"}], "latest": {"action": "BUY", "amount": 198528.75, "date": "2005-12-09", "score": 50.4, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000100579405000970/0001005794-05-000970-index.htm"}}, {"who": "Daniel R. Hamilton", "who_key": "HAMILTON DANIEL R", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 13592.0, "net": -13592.0, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 13592.0, "date": "2003-12-09", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000100579403000403/0001005794-03-000403-index.htm"}], "latest": {"action": "SELL", "amount": 13592.0, "date": "2003-12-09", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000100579403000403/0001005794-03-000403-index.htm"}}, {"who": "John R. Glass", "who_key": "Glass John R", "role": "See Remarks", "person_type": "EXEC", "person_label": "Execs", "bought": 10791.59, "sold": 0, "net": 10791.59, "trades": 1, "top_score": 37.9, "lean": "buying", "history": [{"action": "BUY", "amount": 10791.59, "date": "2017-12-14", "score": 37.9, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000089924317028955/0000899243-17-028955-index.htm"}], "latest": {"action": "BUY", "amount": 10791.59, "date": "2017-12-14", "score": 37.9, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000089924317028955/0000899243-17-028955-index.htm"}}, {"who": "Jan Koe", "who_key": "Koe Jan", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 0, "net": 0, "trades": 1, "top_score": 18.1, "lean": "buying", "history": [{"action": "BUY", "amount": 0, "date": "2013-09-20", "score": 18.1, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036113036922/0001140361-13-036922-index.htm"}], "latest": {"action": "BUY", "amount": 0, "date": "2013-09-20", "score": 18.1, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036113036922/0001140361-13-036922-index.htm"}}, {"who": "Peter R. Culpepper", "who_key": "CULPEPPER PETER R", "role": "CFO, COO", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 0, "net": 0, "trades": 2, "top_score": 25.5, "lean": "buying", "history": [{"action": "BUY", "amount": 0, "date": "2012-12-03", "score": 25.0, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036112049419/0001140361-12-049419-index.htm"}, {"action": "BUY", "amount": 0, "date": "2012-11-16", "score": 25.5, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036112048272/0001140361-12-048272-index.htm"}], "latest": {"action": "BUY", "amount": 0, "date": "2012-12-03", "score": 25.0, "source_url": "https://www.sec.gov/Archives/edgar/data/315545/000114036112049419/0001140361-12-049419-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-10-30", "title": "Insider transaction", "accession": "0001493152-26-049383", "price_sensitive": false}, {"form": "4", "date": "2026-10-23", "title": "Insider transaction", "accession": "0001493152-26-048321", "price_sensitive": false}, {"form": "4", "date": "2026-10-13", "title": "Insider transaction", "accession": "0001493152-26-046701", "price_sensitive": false}, {"form": "4", "date": "2026-10-05", "title": "Insider transaction", "accession": "0001493152-26-045713", "price_sensitive": false}, {"form": "4", "date": "2026-09-18", "title": "Insider transaction", "accession": "0001493152-26-043276", "price_sensitive": false}, {"form": "4", "date": "2026-09-11", "title": "Insider transaction", "accession": "0001493152-26-042331", "price_sensitive": false}, {"form": "4", "date": "2026-09-08", "title": "Insider transaction", "accession": "0001493152-26-041727", "price_sensitive": false}, {"form": "4", "date": "2026-08-26", "title": "Insider transaction", "accession": "0001493152-26-040207", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-13", "title": "Quarterly report", "accession": "0001493152-26-037671", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-07-22", "title": "Form SCHEDULE 13D/A", "accession": "0001493152-26-034217", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "Insider transaction", "accession": "0001493152-26-031718", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-01", "title": "Material event", "accession": "0001493152-26-031379", "price_sensitive": true}, {"form": "4", "date": "2026-06-30", "title": "Insider transaction", "accession": "0001493152-26-031404", "price_sensitive": false}, {"form": "4", "date": "2026-06-30", "title": "Insider transaction", "accession": "0001493152-26-031403", "price_sensitive": false}, {"form": "4", "date": "2026-06-30", "title": "Insider transaction", "accession": "0001493152-26-031402", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-22", "title": "Material event", "accession": "0001493152-26-029512", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-18", "title": "Material event", "accession": "0001493152-26-029280", "price_sensitive": true}, {"form": "4", "date": "2026-06-05", "title": "Insider transaction", "accession": "0001493152-26-027467", "price_sensitive": false}, {"form": "4", "date": "2026-05-29", "title": "Insider transaction", "accession": "0001493152-26-026269", "price_sensitive": false}, {"form": "4", "date": "2026-05-26", "title": "Insider transaction", "accession": "0001493152-26-025188", "price_sensitive": false}, {"form": "4", "date": "2026-05-15", "title": "Insider transaction", "accession": "0001493152-26-023486", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-14", "title": "Quarterly report", "accession": "0001493152-26-022950", "price_sensitive": true}, {"form": "4", "date": "2026-05-07", "title": "Insider transaction", "accession": "0001493152-26-021663", "price_sensitive": false}, {"form": "ARS", "date": "2026-04-30", "title": "Form ARS", "accession": "0001493152-26-019810", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-30", "title": "Form DEFA14A", "accession": "0001493152-26-019807", "price_sensitive": false}], "performance": {"ticker": "PVCT", "has_prices": false, "summary": null, "buys": [{"who": "Glass John R", "person_type": "EXEC", "person_label": "Execs", "role": "See Remarks", "amount": 10791.59, "date": "2017-12-14", "score": 37.9, "ref_price": null, "return": null}, {"who": "Koe Jan", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 0.0, "date": "2013-09-20", "score": 18.1, "ref_price": null, "return": null}, {"who": "CULPEPPER PETER R", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CFO, COO", "amount": 0.0, "date": "2012-12-03", "score": 25.0, "ref_price": null, "return": null}, {"who": "CULPEPPER PETER R", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CFO, COO", "amount": 0.0, "date": "2012-11-16", "score": 25.5, "ref_price": null, "return": null}, {"who": "ADAMS DONALD E", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 713000.4, "date": "2007-01-27", "score": 48.8, "ref_price": null, "return": null}, {"who": "ADAMS DONALD E", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 713000.4, "date": "2007-01-27", "score": 48.8, "ref_price": null, "return": null}, {"who": "ADAMS DONALD E", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 62800.0, "date": "2006-05-24", "score": 34.2, "ref_price": null, "return": null}, {"who": "WACHTER ERIC PHD", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Vice President Pharmaceuticals, Director", "amount": 198528.75, "date": "2005-12-09", "score": 50.4, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}